CENTRAL VALLEY ADVISORS, LLC

Position in ABBV — AbbVie Inc.

CIK 2010698 SACRAMENTO, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$473,837

+$64,957 QoQ

Shares Held

1,883

+0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#3,214

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 99% Shared 1% None 0%

Healthcare · as of Jun 30, 2026

CENTRAL VALLEY ADVISORS, LLC holds $2,448,412 across 5 Drug Manufacturers - General names. ABBV ranks #2 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,091	$1,038,990
2	ABBV	AbbVie Inc. This page	1,883	$473,837
3	LLY	ELI LILLY & Co	310	$371,823
4	MRK	Merck & Co., Inc.	2,648	$340,268
5	GILD	Gilead Sciences, Inc.	1,769	$223,494

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$473,837	1,883	+0.2%	Shares	Sole	2026-07-22
2026-03-31	$408,880	1,880	0.0%	Shares	Sole	2026-04-09
2025-12-31	$429,560	1,880	0.0%	Shares	Sole	2026-01-12
2025-09-30	$435,294	1,880	+0.3%	Shares	Sole	2025-10-09
2025-06-30	$348,037	1,875	-0.4%	Shares	Defined	2025-07-09
2025-03-31	$394,525	1,883	-10.4%	Shares	Sole	2025-04-15
2024-12-31	$373,525	2,102	+0.1%	Shares	Sole	2025-01-15
2024-09-30	$414,707	2,100	-0.1%	Shares	Sole	2024-10-04
2024-06-30	$360,706	2,103	0.0%	Shares	Sole	2024-07-12
2024-03-31	$382,955	2,103	-0.5%	Shares	Defined	2024-04-12
2023-12-31	$327,451	2,113	—	Shares	Sole	2024-02-09
No filing history on record for this holder in this stock.